Bellerophon Therapeutics Stock Filter Stocks by Fundamentals
Bellerophon Therapeutics fundamentals help investors to digest information that contributes to Bellerophon Therapeutics' financial success or failures. It also enables traders to predict the movement of Bellerophon Pink Sheet. The fundamental analysis module provides a way to measure Bellerophon Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bellerophon Therapeutics pink sheet.
Bellerophon |
Did you try this?
Run Price Exposure Probability Now
Price Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets |
All Next | Launch Module |
Bellerophon Fundamentals
Return On Equity | -1.39 | |||
Return On Asset | -0.6 | |||
Profit Margin | (2.20) % | |||
Operating Margin | (2.48) % | |||
Current Valuation | (9.32 M) | |||
Shares Outstanding | 12.23 M | |||
Shares Owned By Insiders | 3.97 % | |||
Shares Owned By Institutions | 45.08 % | |||
Number Of Shares Shorted | 90.45 K | |||
Price To Earning | 5.33 X | |||
Price To Book | 1.05 X | |||
EBITDA | (22.39 M) | |||
Net Income | (19.83 M) | |||
Cash And Equivalents | 16.33 M | |||
Cash Per Share | 1.71 X | |||
Total Debt | 203 K | |||
Debt To Equity | 0.05 % | |||
Current Ratio | 3.12 X | |||
Book Value Per Share | 0.46 X | |||
Cash Flow From Operations | (17.77 M) | |||
Short Ratio | 1.26 X | |||
Earnings Per Share | (0.34) X | |||
Target Price | 2.0 | |||
Number Of Employees | 18 | |||
Beta | 0.55 | |||
Market Capitalization | 1.25 M | |||
Total Asset | 7.93 M | |||
Retained Earnings | (252.08 M) | |||
Working Capital | 2.16 M | |||
Current Asset | 29.45 M | |||
Current Liabilities | 8.07 M | |||
Z Score | -49.75 | |||
Net Asset | 7.93 M |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Bellerophon Pink Sheet
If you are still planning to invest in Bellerophon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellerophon Therapeutics' history and understand the potential risks before investing.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |